<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1395w–111" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1395w–111/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1395w–111/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1395w_111"><akn:num>1395w–111</akn:num><akn:heading>PDP regions; submission of bids; plan approval</akn:heading><akn:content><akn:p>§ 1395w–111. PDP regions; submission of bids; plan approval(a) Establishment of PDP regions; service areas(1) Coverage of entire PDP regionThe service area for a prescription drug plan shall consist of an entire PDP region established under paragraph (2).


(2) Establishment of PDP regions(A) In generalThe Secretary shall establish, and may revise, PDP regions in a manner that is consistent with the requirements for the establishment and revision of MA regions under subparagraphs (B) and (C) of section 1395w–27a(a)(2) of this title.


(B) Relation to MA regionsTo the extent practicable, PDP regions shall be the same as MA regions under section 1395w–27a(a)(2) of this title. The Secretary may establish PDP regions which are not the same as MA regions if the Secretary determines that the establishment of different regions under this part would improve access to benefits under this part.


(C) Authority for territoriesThe Secretary shall establish, and may revise, PDP regions for areas in States that are not within the 50 States or the District of Columbia.



(3) National planNothing in this subsection shall be construed as preventing a prescription drug plan from being offered in more than one PDP region (including all PDP regions).



(b) Submission of bids, premiums, and related information(1) In generalA PDP sponsor shall submit to the Secretary information described in paragraph (2) with respect to each prescription drug plan it offers. Such information shall be submitted at the same time and in a similar manner to the manner in which information described in paragraph (6) of section 1395w–24(a) of this title is submitted by an MA organization under paragraph (1) of such section.


(2) Information describedThe information described in this paragraph is information on the following:(A) Coverage providedThe prescription drug coverage provided under the plan, including the deductible and other cost-sharing.


(B) Actuarial valueThe actuarial value of the qualified p</akn:p></akn:content><akn:subsection eId="subsec_1395w_111_a"><akn:num>(a)</akn:num><akn:heading>Establishment of PDP regions; service areas</akn:heading><akn:content><akn:p>(a) Establishment of PDP regions; service areas</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_b"><akn:num>(b)</akn:num><akn:heading>Submission of bids, premiums, and related information</akn:heading><akn:content><akn:p>(b) Submission of bids, premiums, and related information</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_c"><akn:num>(c)</akn:num><akn:heading>Actuarial valuation</akn:heading><akn:content><akn:p>(c) Actuarial valuation</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_d"><akn:num>(d)</akn:num><akn:heading>Review of information and negotiation</akn:heading><akn:content><akn:p>(d) Review of information and negotiation</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_e"><akn:num>(e)</akn:num><akn:heading>Approval of proposed plans</akn:heading><akn:content><akn:p>(e) Approval of proposed plans</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_f"><akn:num>(f)</akn:num><akn:heading>Application of limited risk plans</akn:heading><akn:content><akn:p>(f) Application of limited risk plans</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_g"><akn:num>(g)</akn:num><akn:heading>Guaranteeing access to coverage</akn:heading><akn:content><akn:p>(g) Guaranteeing access to coverage</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_h"><akn:num>(h)</akn:num><akn:heading>Annual report on use of limited risk plans and fallback plans</akn:heading><akn:content><akn:p>(h) Annual report on use of limited risk plans and fallback plans The Secretary shall submit to Congress an annual report that describes instances in which limited risk plans and fallback prescription drug plans were offered under subsections (f) and (g). The Secretary shall include in such report such recommendations as may be appropriate to limit the need for the provision of such plans and to maximize the assumption of financial risk under section subsection 33 So in original. (f).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_i"><akn:num>(i)</akn:num><akn:heading>Noninterference</akn:heading><akn:content><akn:p>(i) Noninterference In order to promote competition under this part and in carrying out this part, the Secretary—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_111_j"><akn:num>(j)</akn:num><akn:heading>Coordination of benefits</akn:heading><akn:content><akn:p>(j) Coordination of benefits A PDP sponsor offering a prescription drug plan shall permit State Pharmaceutical Assistance Programs and Rx plans under sections 1395w–133 and 1395w–134 of this title to coordinate benefits with the plan and, in connection with such coordination with such a Program, not to impose fees that are unrelated to the cost of coordination.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>